Square Pharmaceuticals PLC has received the Excellence in Investment Award 2025 under the Local Investment category at the inaugural Bangladesh Investment Summit.

The award was presented by the Bangladesh Investment Development Authority (BIDA) in recognition of the company’s contribution to sustainable economic growth, employment generation, infrastructure development, and innovation.

Mr. Eric S. Chowdhury, Director of Square Pharmaceuticals PLC, accepted the award from Chief Adviser Professor Dr. Muhammad Yunus, Executive Chairman of BIDA Mr. Chowdhury Ashik Mahmud Bin Harun, and Chief Adviser's Special Envoy on International Affairs Mr. Lutfey Siddiqi.

Square Pharmaceuticals PLC is one of the leading pharmaceutical companies in Bangladesh, engaged in the manufacturing and marketing of a wide range of generic pharmaceutical products. The company operates multiple state-of-the-art manufacturing facilities and maintains compliance with international regulatory standards. As part of its global expansion, Square Pharmaceuticals PLC has extended its presence to Kenya, furthering its commitment to delivering quality healthcare solutions worldwide.

The company has a significant footprint in domestic and export markets, supplying pharmaceutical products to over 40 countries. Its continued investment in technology, capacity expansion, and a skilled workforce support its operational growth and contribution to the national economy.

BDST: 1632 HRS, April 9, 2025
MSK